(Q70278555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351340%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351340%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

S. Louie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6351340

5 October 2023

V. Gurewich

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6351340

5 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6351340

5 October 2023

publication date

1 May 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351340%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

15 May 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6351340

full work available at URL

5 October 2023

https://api.elsevier.com/content/article/PII:0049384883902244?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

https://api.elsevier.com/content/article/PII:0049384883902244?httpAccept=text/plain

5 October 2023

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

5 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351340%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351340%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351340%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

323-335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351340%20AND%20SRC:MED&resulttype=core&format=json

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

10 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

5 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

5 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

5 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin

5 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Protection by aspirin against experimentally induced arterial thrombosis in dogs

5 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

5 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Controlled trial of aspirin in cerebral ischemia

5 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

5 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Effect of anticoagulants and inhibitors of platelet aggregation on thrombotic occlusion of endarterectomized cat carotid arteries

5 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Failure of aspirin at different doses to modify experimental thrombosis in rats

5 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Differential effects of two doses of aspirin on platelets-vessel wall introduction in vivo

5 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose Aspirin

5 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin

5 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Mode of action of dipyridamole on human platelets

5 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Dipyridamole and Aspirin in Relation to Platelet Aggregation and Vessel Wall Prostaglandin Generation

5 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

The synergistic effect of aspirin and dipyridamole upon platelet thrombi in living blood vessels

5 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

The effect of combined aspirin and dipyridamole therapy on thrombus formation in an arterial thrombogenic lesion in the dog

5 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin

5 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations

5 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

5 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Evaluation of antithrombotic properties of suloctidil in comparison with aspirin and dipyridamole

5 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase

5 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity

5 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Differential inhibition of prostacyclin production and platelet aggregation by aspirin

5 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Dosage of acetylsalicylic acid for inhibition of platelet function

5 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

Aspirin: A paradoxical effect on bleeding-time

5 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90224-4

5 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351340%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference